GO:0043759 2-methylbutanoate-CoA ligase activity

2-methylbutanoate-CoA ligase activity (GO:0043759) is a molecular function that catalyzes the ATP-dependent formation of a thioester bond between 2-methylbutanoate and coenzyme A, yielding 2-methylbutanoyl-CoA, AMP, and diphosphate. This reaction is a key activation step for branched-chain short-chain fatty acids, allowing them to enter downstream metabolic pathways such as beta-oxidation and acyl-CoA-dependent conjugation. The enzyme belongs to the ANL superfamily of adenylate-forming enzymes, which includes acyl-CoA synthetases and luciferases. Researchers study GO:0043759 because it sits at the interface of amino acid catabolism, fatty acid metabolism, and detoxification of branched-chain organic acids. In humans, defects in branched-chain acyl-CoA metabolism are linked to organic acidurias and mitochondrial dysfunction, and the enzyme's substrates and products are diagnostic markers in newborn screening. Understanding the catalytic mechanism and regulation of this activity is therefore relevant to inherited metabolic disease, metabolic engineering, and the development of small-molecule modulators. This article summarizes the QuickGO definition, the catalytic mechanism, the genes and proteins associated with the term, disease connections, and the experimental models and methods used to study 2-methylbutanoate-CoA ligase activity.

According to QuickGO, GO:0043759 is defined as the catalysis of the reaction: ATP + 2-methylbutanoate + CoA = AMP + diphosphate + 2-methylbutanoyl-CoA. In other words, the enzyme uses the energy of ATP hydrolysis to activate the carboxylate group of 2-methylbutanoate, forming a reactive acyl-AMP intermediate that then reacts with coenzyme A to produce the thioester 2-methylbutanoyl-CoA. The term is a molecular_function in the Gene Ontology and is synonymous with branched-chain acyl-CoA synthetase (ADP-forming) activity.

GO:0043759 is important because it controls the entry of 2-methylbutanoate into acyl-CoA-dependent metabolic pathways, and its dysfunction can lead to the accumulation of branched-chain organic acids that are toxic to mitochondria and the central nervous system. The reaction is also a model for understanding the broader ANL superfamily of adenylate-forming enzymes, which includes acyl-CoA synthetases, peptide synthetases, and firefly luciferase. Because the enzyme produces 2-methylbutanoyl-CoA, a metabolite that can feed into beta-oxidation and anaplerotic pathways, its activity influences cellular energy homeostasis and metabolic flux.

The following genes and proteins are associated with 2-methylbutanoate-CoA ligase activity or with the branched-chain acyl-CoA metabolic pathways in which this activity operates.

The activity of 2-methylbutanoate-CoA ligase is regulated at multiple levels. Transcriptionally, the expression of acyl-CoA synthetase genes can be induced by peroxisome proliferator-activated receptor alpha (PPARA) and other nuclear receptors in response to lipid availability. Post-translationally, the enzyme may be modified by phosphorylation or acetylation, although specific sites for GO:0043759 enzymes are not well defined. Metabolically, the reaction is controlled by the availability of 2-methylbutanoate, CoA, and ATP, and by the cellular energy charge. In mitochondria, the activity is also influenced by the redox state and by the transport of substrates across the inner membrane.

Defects in the activation or downstream oxidation of 2-methylbutanoyl-CoA can cause organic acidurias, including 2-methylbutyryl-CoA dehydrogenase deficiency and related disorders. Patients may present with developmental delay, seizures, and metabolic acidosis, and the diagnosis relies on detecting elevated 2-methylbutanoylglycine and other metabolites in urine. The enzyme activity of GO:0043759 is therefore relevant to the biochemical workup of these conditions.

Because the reaction consumes ATP and produces a mitochondrial acyl-CoA, impaired 2-methylbutanoate-CoA ligase activity can contribute to mitochondrial energy stress. Studies of mitochondrial quality control, such as those on PINK1 and Parkin, highlight how metabolic and mitochondrial defects intersect with cellular stress responses. Loss of acyl-CoA ligase function may therefore sensitize cells to oxidative stress and ferroptosis-related pathways.

Branched-chain acyl-CoA ligases are used in metabolic engineering to convert branched-chain alcohols and acids into esters and other value-added products. Understanding the substrate specificity and kinetics of GO:0043759 enzymes enables the design of pathways for biofuel and flavor compound production. CRISPR-based genome editing can be used to optimize these pathways in microbial and plant hosts.

The activity of GO:0043759 can be measured by coupling the formation of AMP to a NADH-consuming enzyme system, or by directly detecting 2-methylbutanoyl-CoA using liquid chromatography-mass spectrometry (LC-MS). Radioactive ATP-based assays can also be used to monitor the adenylation step. These methods allow determination of kinetic parameters such as Km and Vmax for the substrates.

LC-MS-based metabolomics can quantify 2-methylbutanoate, 2-methylbutanoyl-CoA, and related CoA thioesters in cell and tissue extracts. Stable isotope labeling with 13C-isoleucine or 13C-2-methylbutanoate can trace flux through the enzyme. These approaches are essential for linking genotype to metabolic phenotype in CRISPR models.

Genome-wide CRISPR knockout or activation screens can identify genes that modify the cellular response to 2-methylbutanoate or that regulate acyl-CoA levels. Such screens can be performed in cell lines with a reporter for mitochondrial stress or lipid accumulation. Hits can then be validated by targeted knockout and metabolomic analysis.

X-ray crystallography and cryo-electron microscopy can determine the structure of the enzyme in complex with substrates or inhibitors. Isothermal titration calorimetry and surface plasmon resonance can measure binding affinities for CoA and ATP. These methods provide a mechanistic basis for understanding catalysis and for drug design.

Researchers studying 2-methylbutanoate-CoA ligase activity-related genes often need to determine whether a candidate gene is causally involved in a metabolic or disease phenotype. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for functional studies of GO:0043759 and its associated pathways.

2-methylbutanoate-CoA ligase activity (GO:0043759) is a key enzymatic step in branched-chain acyl-CoA metabolism, with important implications for inherited metabolic disorders, mitochondrial function, and metabolic engineering. Understanding its mechanism, regulation, and physiological roles requires integrated approaches including CRISPR-based genome editing, metabolomics, and structural biology. EDITGENE provides end-to-end CRISPR services to accelerate research on GO:0043759 and its associated genes, from knockout and knock-in models to library screening and bioinformatics.